Estimating the efficacy of symptom-based screening for COVID-19

There is substantial interest in using presenting symptoms to prioritize testing for COVID-19 and establish symptom-based surveillance. However, little is currently known about the specificity of COVID-19 symptoms. To assess the feasibility of symptom-based screening for COVID-19, we used data from...

Full description

Saved in:
Bibliographic Details
Published in:NPJ digital medicine 2020-07, Vol.3 (1), p.95-95, Article 95
Main Authors: Callahan, Alison, Steinberg, Ethan, Fries, Jason A., Gombar, Saurabh, Patel, Birju, Corbin, Conor K., Shah, Nigam H.
Format: Article
Language:English
Subjects:
692/308/174
692/699/255/2514
Biomedicine
Biotechnology
Brief Communication
Coronaviruses
COVID-19
Digital technology
Health informatics
Medical diagnosis
Medicine
Medicine & Public Health
Severe acute respiratory syndrome coronavirus 2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c547t-f71d958752c387db66e7d0872eede04757cedd3f1056b4ca9d7103434d2271423
cites cdi_FETCH-LOGICAL-c547t-f71d958752c387db66e7d0872eede04757cedd3f1056b4ca9d7103434d2271423
container_end_page 95
container_issue 1
container_start_page 95
container_title NPJ digital medicine
container_volume 3
creator Callahan, Alison
Steinberg, Ethan
Fries, Jason A.
Gombar, Saurabh
Patel, Birju
Corbin, Conor K.
Shah, Nigam H.
description There is substantial interest in using presenting symptoms to prioritize testing for COVID-19 and establish symptom-based surveillance. However, little is currently known about the specificity of COVID-19 symptoms. To assess the feasibility of symptom-based screening for COVID-19, we used data from tests for common respiratory viruses and SARS-CoV-2 in our health system to measure the ability to correctly classify virus test results based on presenting symptoms. Based on these results, symptom-based screening may not be an effective strategy to identify individuals who should be tested for SARS-CoV-2 infection or to obtain a leading indicator of new COVID-19 cases.
doi_str_mv 10.1038/s41746-020-0300-0
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4b6dacc167ee4967afd5c1aa4e12f942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4b6dacc167ee4967afd5c1aa4e12f942</doaj_id><sourcerecordid>2528863215</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-f71d958752c387db66e7d0872eede04757cedd3f1056b4ca9d7103434d2271423</originalsourceid><addsrcrecordid>eNp1kctqGzEUhkVoSILjB-imDHTTzaS6a7QqxXFSQ8CbpFuhkY7cMZ6RK40XfvvImSQthW7OEdKn_1x-hD4SfEMwa75mThSXNaa4xgyXcIauKNNNLZmgH_46X6J5zluMC8kbzeUFumRMaKUwvkLflnnsejt2w6Yaf0EFIXTOumMVQ5WP_X6Mfd3aDL7KLgEMJy7EVC3WP1e3NdHX6DzYXYb5a56hp7vl4-JH_bC-Xy2-P9ROcDXWQRGvRaMEdaxRvpUSlMeNogAeMFdCOfCeBYKFbLmz2qsyJGfcU6oIp2yGVpOuj3Zr9qn0nI4m2s68XMS0MTaNnduB4a301jkiFQDXUtnghSPWciA06BetL5PWPsXfB8ij6bvsYLezA8RDNpRTWXarqSzo53_QbTykoUxqqKBNIxklolBkolyKOScI7w0SbE5mmcksUywwJ7NKmKFPr8qHtgf__uPNmgLQCcjladhA-lP6_6rPwmKbdw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528863215</pqid></control><display><type>article</type><title>Estimating the efficacy of symptom-based screening for COVID-19</title><source>Open Access: PubMed Central</source><source>ProQuest - Publicly Available Content Database</source><source>Alma/SFX Local Collection</source><source>Coronavirus Research Database</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Callahan, Alison ; Steinberg, Ethan ; Fries, Jason A. ; Gombar, Saurabh ; Patel, Birju ; Corbin, Conor K. ; Shah, Nigam H.</creator><creatorcontrib>Callahan, Alison ; Steinberg, Ethan ; Fries, Jason A. ; Gombar, Saurabh ; Patel, Birju ; Corbin, Conor K. ; Shah, Nigam H.</creatorcontrib><description>There is substantial interest in using presenting symptoms to prioritize testing for COVID-19 and establish symptom-based surveillance. However, little is currently known about the specificity of COVID-19 symptoms. To assess the feasibility of symptom-based screening for COVID-19, we used data from tests for common respiratory viruses and SARS-CoV-2 in our health system to measure the ability to correctly classify virus test results based on presenting symptoms. Based on these results, symptom-based screening may not be an effective strategy to identify individuals who should be tested for SARS-CoV-2 infection or to obtain a leading indicator of new COVID-19 cases.</description><identifier>ISSN: 2398-6352</identifier><identifier>EISSN: 2398-6352</identifier><identifier>DOI: 10.1038/s41746-020-0300-0</identifier><identifier>PMID: 33597700</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/174 ; 692/699/255/2514 ; Biomedicine ; Biotechnology ; Brief Communication ; Coronaviruses ; COVID-19 ; Digital technology ; Health informatics ; Medical diagnosis ; Medicine ; Medicine &amp; Public Health ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>NPJ digital medicine, 2020-07, Vol.3 (1), p.95-95, Article 95</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-f71d958752c387db66e7d0872eede04757cedd3f1056b4ca9d7103434d2271423</citedby><cites>FETCH-LOGICAL-c547t-f71d958752c387db66e7d0872eede04757cedd3f1056b4ca9d7103434d2271423</cites><orcidid>0000-0002-5581-8569 ; 0000-0001-5163-380X ; 0000-0001-7166-5032 ; 0000-0001-7673-6143</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2528863215?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,38516,43895,44590</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33597700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Callahan, Alison</creatorcontrib><creatorcontrib>Steinberg, Ethan</creatorcontrib><creatorcontrib>Fries, Jason A.</creatorcontrib><creatorcontrib>Gombar, Saurabh</creatorcontrib><creatorcontrib>Patel, Birju</creatorcontrib><creatorcontrib>Corbin, Conor K.</creatorcontrib><creatorcontrib>Shah, Nigam H.</creatorcontrib><title>Estimating the efficacy of symptom-based screening for COVID-19</title><title>NPJ digital medicine</title><addtitle>npj Digit. Med</addtitle><addtitle>NPJ Digit Med</addtitle><description>There is substantial interest in using presenting symptoms to prioritize testing for COVID-19 and establish symptom-based surveillance. However, little is currently known about the specificity of COVID-19 symptoms. To assess the feasibility of symptom-based screening for COVID-19, we used data from tests for common respiratory viruses and SARS-CoV-2 in our health system to measure the ability to correctly classify virus test results based on presenting symptoms. Based on these results, symptom-based screening may not be an effective strategy to identify individuals who should be tested for SARS-CoV-2 infection or to obtain a leading indicator of new COVID-19 cases.</description><subject>692/308/174</subject><subject>692/699/255/2514</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Brief Communication</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Digital technology</subject><subject>Health informatics</subject><subject>Medical diagnosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>2398-6352</issn><issn>2398-6352</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kctqGzEUhkVoSILjB-imDHTTzaS6a7QqxXFSQ8CbpFuhkY7cMZ6RK40XfvvImSQthW7OEdKn_1x-hD4SfEMwa75mThSXNaa4xgyXcIauKNNNLZmgH_46X6J5zluMC8kbzeUFumRMaKUwvkLflnnsejt2w6Yaf0EFIXTOumMVQ5WP_X6Mfd3aDL7KLgEMJy7EVC3WP1e3NdHX6DzYXYb5a56hp7vl4-JH_bC-Xy2-P9ROcDXWQRGvRaMEdaxRvpUSlMeNogAeMFdCOfCeBYKFbLmz2qsyJGfcU6oIp2yGVpOuj3Zr9qn0nI4m2s68XMS0MTaNnduB4a301jkiFQDXUtnghSPWciA06BetL5PWPsXfB8ij6bvsYLezA8RDNpRTWXarqSzo53_QbTykoUxqqKBNIxklolBkolyKOScI7w0SbE5mmcksUywwJ7NKmKFPr8qHtgf__uPNmgLQCcjladhA-lP6_6rPwmKbdw</recordid><startdate>20200713</startdate><enddate>20200713</enddate><creator>Callahan, Alison</creator><creator>Steinberg, Ethan</creator><creator>Fries, Jason A.</creator><creator>Gombar, Saurabh</creator><creator>Patel, Birju</creator><creator>Corbin, Conor K.</creator><creator>Shah, Nigam H.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5581-8569</orcidid><orcidid>https://orcid.org/0000-0001-5163-380X</orcidid><orcidid>https://orcid.org/0000-0001-7166-5032</orcidid><orcidid>https://orcid.org/0000-0001-7673-6143</orcidid></search><sort><creationdate>20200713</creationdate><title>Estimating the efficacy of symptom-based screening for COVID-19</title><author>Callahan, Alison ; Steinberg, Ethan ; Fries, Jason A. ; Gombar, Saurabh ; Patel, Birju ; Corbin, Conor K. ; Shah, Nigam H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-f71d958752c387db66e7d0872eede04757cedd3f1056b4ca9d7103434d2271423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>692/308/174</topic><topic>692/699/255/2514</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Brief Communication</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Digital technology</topic><topic>Health informatics</topic><topic>Medical diagnosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Callahan, Alison</creatorcontrib><creatorcontrib>Steinberg, Ethan</creatorcontrib><creatorcontrib>Fries, Jason A.</creatorcontrib><creatorcontrib>Gombar, Saurabh</creatorcontrib><creatorcontrib>Patel, Birju</creatorcontrib><creatorcontrib>Corbin, Conor K.</creatorcontrib><creatorcontrib>Shah, Nigam H.</creatorcontrib><collection>Springer_OA刊</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals</collection><jtitle>NPJ digital medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Callahan, Alison</au><au>Steinberg, Ethan</au><au>Fries, Jason A.</au><au>Gombar, Saurabh</au><au>Patel, Birju</au><au>Corbin, Conor K.</au><au>Shah, Nigam H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estimating the efficacy of symptom-based screening for COVID-19</atitle><jtitle>NPJ digital medicine</jtitle><stitle>npj Digit. Med</stitle><addtitle>NPJ Digit Med</addtitle><date>2020-07-13</date><risdate>2020</risdate><volume>3</volume><issue>1</issue><spage>95</spage><epage>95</epage><pages>95-95</pages><artnum>95</artnum><issn>2398-6352</issn><eissn>2398-6352</eissn><abstract>There is substantial interest in using presenting symptoms to prioritize testing for COVID-19 and establish symptom-based surveillance. However, little is currently known about the specificity of COVID-19 symptoms. To assess the feasibility of symptom-based screening for COVID-19, we used data from tests for common respiratory viruses and SARS-CoV-2 in our health system to measure the ability to correctly classify virus test results based on presenting symptoms. Based on these results, symptom-based screening may not be an effective strategy to identify individuals who should be tested for SARS-CoV-2 infection or to obtain a leading indicator of new COVID-19 cases.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33597700</pmid><doi>10.1038/s41746-020-0300-0</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-5581-8569</orcidid><orcidid>https://orcid.org/0000-0001-5163-380X</orcidid><orcidid>https://orcid.org/0000-0001-7166-5032</orcidid><orcidid>https://orcid.org/0000-0001-7673-6143</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2398-6352
ispartof NPJ digital medicine, 2020-07, Vol.3 (1), p.95-95, Article 95
issn 2398-6352
2398-6352
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4b6dacc167ee4967afd5c1aa4e12f942
source Open Access: PubMed Central; ProQuest - Publicly Available Content Database; Alma/SFX Local Collection; Coronavirus Research Database; Springer Nature - nature.com Journals - Fully Open Access
subjects 692/308/174
692/699/255/2514
Biomedicine
Biotechnology
Brief Communication
Coronaviruses
COVID-19
Digital technology
Health informatics
Medical diagnosis
Medicine
Medicine & Public Health
Severe acute respiratory syndrome coronavirus 2
title Estimating the efficacy of symptom-based screening for COVID-19
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A18%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estimating%20the%20efficacy%20of%20symptom-based%20screening%20for%20COVID-19&rft.jtitle=NPJ%20digital%20medicine&rft.au=Callahan,%20Alison&rft.date=2020-07-13&rft.volume=3&rft.issue=1&rft.spage=95&rft.epage=95&rft.pages=95-95&rft.artnum=95&rft.issn=2398-6352&rft.eissn=2398-6352&rft_id=info:doi/10.1038/s41746-020-0300-0&rft_dat=%3Cproquest_doaj_%3E2528863215%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c547t-f71d958752c387db66e7d0872eede04757cedd3f1056b4ca9d7103434d2271423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2528863215&rft_id=info:pmid/33597700&rfr_iscdi=true